RR
Rodgers Richard J
董事
BoardM
内部人交易记录
董事尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the complete record of transactions filed by Rodgers Richard J, 董事. Officer active across 4 companies, notably Ardelyx, INC.. Cumulatively, 25 filings have been published. Activity tracked since 16 June 2021. The latest transaction was filed on 20 April 2026 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Rodgers Richard J
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报25 总计
26,455 股Common StockSEC:0001313397-26-000002:0
24,367 股0Common StockSEC:0000905148-26-001788:0
3,800 股Common StockSEC:0001104659-25-104413:0
21,468 股0Common StockSEC:0001628280-25-032729:0
10,420 股0Common StockSEC:0001593968-25-000759:0
79,504 股0Common StockSEC:0000905148-25-001430:0
100,000 股@ US$0.55100.0% 占其流量Common StockSEC:0001628280-25-001849:0
3,800 股0Common StockSEC:0001593968-25-000012:0
12,204 股0Common StockSEC:0001628280-24-028604:0
6,670 股0Common StockSEC:0001593968-24-000860:0
41,143 股0Common StockSEC:0000905148-24-001714:0
24,762 股Common StockSEC:0001140361-24-000494:0
35,000 股0Common StockSEC:0001140361-23-052986:0
3,800 股Common StockSEC:0001209191-23-053952:0
18,494 股0Common StockSEC:0001628280-23-022556:0
50,000 股0Common StockSEC:0001140361-23-019675:0
20,822 股Common StockSEC:0001140361-23-001514:0
3,148 股@ US$0.0001100.0% 占其流量Common StockSEC:0001140361-22-035953:0
7,812 股Common StockSEC:0001140361-22-025286:0
132,299 股0Common StockSEC:0001567619-22-013086:0
4,629 股Common StockSEC:0001140361-22-013060:0
4,021 股Common StockSEC:0001140361-22-000659:0
2,912 股Common StockSEC:0001140361-21-033450:0
2,840 股Common StockSEC:0001140361-21-023334:0
9,917 股0Common StockSEC:0001567619-21-012429:0
About Rodgers Richard J
Rodgers Richard J is Administrateur and serves as a director at Ocuphire Pharma, Inc., Ardelyx, INC., NOVAVAX INC and Opus Genetics, Inc. The record shows 25 filings in total, with sampled recent filings from 2021-06-21 to 2026-06-18, and a transaction nature mainly indicated as Attribution; in these recent filings, both buy and sell amounts are 0 EUR.